Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes.
暂无分享,去创建一个
[1] Pengfei Guo,et al. A meta-analysis of randomized controlled trials , 2019, Medicine.
[2] F. Jin,et al. Enteral Immunomodulatory Diet (Omega-3 Fatty Acid, γ-Linolenic Acid and Antioxidant Supplementation) for Acute Lung Injury and Acute Respiratory Distress Syndrome: An Updated Systematic Review and Meta-Analysis , 2015, Nutrients.
[3] K. Jung,et al. Dihomo-γ-linolenic acid prevents the development of atopic dermatitis through prostaglandin D1 production in NC/Tnd mice. , 2015, Journal of dermatological science.
[4] W. Ling,et al. Endothelium-Dependent Relaxation Effect of Apocynum venetum Leaf Extract via Src/PI3K/Akt Signalling Pathway , 2015, Nutrients.
[5] P. Ivester,et al. The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population , 2014, Lipids in Health and Disease.
[6] Kai-yu Raymond Tong,et al. Assisted technology for daily living , 2014, SpringerPlus.
[7] E. Israel,et al. LTC4 synthase polymorphism modifies efficacy of botanical seed oil combination in asthma , 2014, SpringerPlus.
[8] Philip C. Calder,et al. Supplementation with N-3 Long-Chain Polyunsaturated Fatty Acids or Olive Oil in Men and Women with Renal Disease Induces Differential Changes in the DNA Methylation of FADS2 and ELOVL5 in Peripheral Blood Mononuclear Cells , 2014, PloS one.
[9] R. Mathias,et al. Relationship between a Common Variant in the Fatty Acid Desaturase (FADS) Cluster and Eicosanoid Generation in Humans* , 2014, The Journal of Biological Chemistry.
[10] R. Mathias,et al. Diet-Gene Interactions and PUFA Metabolism: A Potential Contributor to Health Disparities and Human Diseases , 2014, Nutrients.
[11] R. Mathias,et al. Genetic Variants in the FADS Gene: Implications for Dietary Recommendations for Fatty Acid Intake , 2014, Current Nutrition Reports.
[12] G. Hawkins,et al. DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver , 2014, PloS one.
[13] P. Schmid‐Grendelmeier,et al. Gamma-Linolenic Acid Levels Correlate with Clinical Efficacy of Evening Primrose Oil in Patients with Atopic Dermatitis , 2014, Advances in Therapy.
[14] E. Israel,et al. Impact of botanical oils on polyunsaturated fatty acid metabolism and leukotriene generation in mild asthmatics , 2013, Lipids in Health and Disease.
[15] F. Chilton,et al. Stearidonic and γ-linolenic acids in echium oil improves glucose disposal in insulin resistant monkeys. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.
[16] P. Calder. Long chain fatty acids and gene expression in inflammation and immunity , 2013, Current opinion in clinical nutrition and metabolic care.
[17] Sujoy Ray,et al. Oral evening primrose oil and borage oil for eczema. , 2013, The Cochrane database of systematic reviews.
[18] A. Armstrong,et al. Effect of Nutrient Supplementation on Atopic Dermatitis in Children , 2012 .
[19] An Pan,et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. , 2012, The American journal of clinical nutrition.
[20] U. Jung,et al. Fatty Acids Regulate Endothelial Lipase and Inflammatory Markers in Macrophages and in Mouse Aorta: A Role for PPAR&ggr; , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[21] E. Ntzani,et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.
[22] T. Rice,et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. , 2011, JAMA.
[23] R. Moots,et al. Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review. , 2011, Rheumatology.
[24] C. Langefeld,et al. Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome , 2011, British Journal of Nutrition.
[25] Yang Li,et al. Effects of Omega-3 Fatty Acid for Sudden Cardiac Death Prevention in Patients with Cardiovascular Disease: A Contemporary Meta-Analysis of Randomized, Controlled Trials , 2011, Cardiovascular Drugs and Therapy.
[26] I. Ruczinski,et al. The impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African Americans , 2011, BMC Genetics.
[27] P. Rzehak,et al. Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. , 2011, Maternal & child nutrition.
[28] M. Tecce,et al. Selective regulation of UGT1A1 and SREBP‐1c mRNA expression by docosahexaenoic, eicosapentaenoic, and arachidonic acids , 2011, Journal of cellular physiology.
[29] A. Gismondi,et al. Similar antineoplastic effects of nimesulide, a selective COX-2 inhibitor, and prostaglandin E1 on B16-F10 murine melanoma cells , 2010, Melanoma research.
[30] G. Hardy,et al. Borage oil in the treatment of atopic dermatitis. , 2010, Nutrition.
[31] J. Heinrich,et al. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. , 2010, Metabolism: clinical and experimental.
[32] J. Brophy,et al. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials , 2010, BMC cardiovascular disorders.
[33] P. Ivester,et al. Effect of Dietary Fatty Acids on Inflammatory Gene Expression in Healthy Humans* , 2009, The Journal of Biological Chemistry.
[34] Ping Zhang,et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trials , 2009, Annals of medicine.
[35] Luigi Ferrucci,et al. Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study , 2009, PLoS genetics.
[36] J. Boyce. Eicosanoids in asthma, allergic inflammation, and host defense. , 2008, Current molecular medicine.
[37] A. Simopoulos,et al. The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases , 2008, Experimental biology and medicine.
[38] G. Schmitz,et al. The opposing effects of n-3 and n-6 fatty acids. , 2008, Progress in lipid research.
[39] C. Serhan,et al. Resolvins and protectins in the termination program of acute inflammation. , 2007, Trends in immunology.
[40] N. Morse,et al. A meta-analysis of randomized, placebo-controlled clinical trials of Efamol evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries? , 2006, Current pharmaceutical biotechnology.
[41] A. Pontes-Arruda,et al. Effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock* , 2006, Critical care medicine.
[42] J. Hibbeln,et al. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. , 2006, The American journal of clinical nutrition.
[43] R. Deckelbaum,et al. n-3 fatty acids and gene expression. , 2006, The American journal of clinical nutrition.
[44] B. Hoff,et al. Lipids in Health and Disease , 2002 .
[45] Jonathan Cohen,et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury* , 2006, Critical care medicine.
[46] R. Kitz,et al. Impact of early dietary gamma‐linolenic acid supplementation on atopic eczema in infancy , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[47] Charles N. Serhan,et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers , 2004, Lipids.
[48] C. di Ilio,et al. Effect of the two different leukotriene receptor antagonists, montelukast and zafirlukast, on quality of life: a 12-week randomized study. , 2004, Allergy and Asthma Proceedings.
[49] M. Zeegers,et al. Oral essential fatty acid supplementation in atopic dermatitis—a meta‐analysis of placebo‐controlled trials , 2004, The British journal of dermatology.
[50] B. Morrissey,et al. Suppression of Leukotriene B4 Generation by Ex-vivo Neutrophils Isolated from Asthma Patients on Dietary Supplementation with Gammalinolenic Acid-containing Borage Oil: Possible Implication in Asthma , 2004, Clinical & developmental immunology.
[51] P. Christmas,et al. The organization and consequences of eicosanoid signaling. , 2003, The Journal of clinical investigation.
[52] F. Chilton,et al. Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. , 2003, Clinical therapeutics.
[53] F. Chilton,et al. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. , 2003, Clinical therapeutics.
[54] J. Moreau,et al. Prostaglandins Inhibit 5-Lipoxygenase-Activating Protein Expression and Leukotriene B4 Production from Dendritic Cells Via an IL-10-Dependent Mechanism1 , 2003, The Journal of Immunology.
[55] C. Serhan,et al. Resolvins , 2002, The Journal of experimental medicine.
[56] K. Duffin,et al. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. , 2002, The Biochemical journal.
[57] T. Parsons,et al. Herbal therapy for treating rheumatoid arthritis. , 2000, The Cochrane database of systematic reviews.
[58] B. Staels,et al. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation , 2000, Inflammation Research.
[59] Jilly F. Evans,et al. Characterization of the Human Cysteinyl Leukotriene 2 Receptor* , 2000, The Journal of Biological Chemistry.
[60] A. Fonteh,et al. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. , 2000, The Journal of nutrition.
[61] M. Murray,et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. , 1999, Critical care medicine.
[62] Jilly F. Evans,et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor , 1999, Nature.
[63] R. Chapkin,et al. Importance of Dietary γ-Linolenic Acid in Human Health and Nutrition , 1998 .
[64] P. Amerio,et al. Efficacy of γ-Linolenic Acid in the Treatment of Patients with Atopic Dermatitis , 1997 .
[65] A. Fonteh,et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. , 1997, The Journal of nutrition.
[66] B. Mackey,et al. Effects of dietary arachidonic acid on human immune response , 1997, Lipids.
[67] D. Kyle,et al. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans , 1997, Lipids.
[68] M. Laposata,et al. gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. , 1996, Arthritis and rheumatism.
[69] A. Fonteh,et al. Metabolism of gammalinolenic acid in human neutrophils. , 1996, Journal of immunology.
[70] K. Ramos,et al. Dietary γ-Linolenic Acid Modulates Macrophage–Vascular Smooth Muscle Cell Interactions Evidence for a Macrophage-Derived Soluble Factor That Downregulates DNA Synthesis in Smooth Muscle Cells , 1995 .
[71] N. Salem,et al. Essential fatty acid metabolism in the feline: relationship between liver and brain production of long-chain polyunsaturated fatty acids. , 1994, Journal of lipid research.
[72] E. Boyce,et al. Treatment of rheumatoid arthritis with blackcurrant seed oil. , 1994, British journal of rheumatology.
[73] H. Sprecher,et al. A comparison of the specific activities of linoleate and arachidonate in liver, heart and kidney phospholipids after feeding rats ethyl linoleate-9,10,12,13-d4. , 1994, Biochimica et biophysica acta.
[74] C. Agostoni,et al. The Efficacy and Safety of γ-Linolenic Acid in the Treatment of Infantile Atopic Dermatitis , 1994 .
[75] C. Irazú,et al. Δ5 Desaturase activity in rat kidney microsomes , 1993, Molecular and Cellular Biochemistry.
[76] E. Boyce,et al. Treatment of Rheumatoid Arthritis with Gammalinolenic Acid , 1993, Annals of Internal Medicine.
[77] S. Eaton,et al. Humans, lipids and evolution , 1992, Lipids.
[78] E. Mandon,et al. Arachidonic acid biosynthesis in non-stimulated and adrenocorticotropin-stimulated sertoli and leydig cells , 1992, Lipids.
[79] V. Ziboh,et al. Dietary intake of concentrated gamma-linolenic acid (GLA)-enriched oil suppresses cutaneous level of dihomo-gamma-linolenic acid (DGLA): possible in vivo inhibition of microsomal elongation of GLA to DGLA. , 1992, Prostaglandins, leukotrienes, and essential fatty acids.
[80] R. Chapkin,et al. Utilization of gammalinolenic acid by mouse peritoneal macrophages. , 1991, Biochimica et biophysica acta.
[81] J. Bézard,et al. Delta 5-desaturation of dihomogammalinolenic acid (20:3(n-6)) into arachidonic acid (20:4(n-6)) by rat liver microsomes and incorporation of fatty acids in microsome phospholipids. , 1991, Biochimica et biophysica acta.
[82] L. Iversen,et al. Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophilsin vitro. Evidence of formation of antiinflammatory compounds , 1991, Agents and Actions.
[83] V. Ziboh,et al. Effects of dietary supplementation with eicosapentaenoic acid or gamma-linolenic acid on neutrophil phospholipid fatty acid composition and activation responses , 1990, Inflammation.
[84] Daniel J. Gould,et al. Meta‐analysis of placebo‐controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response , 1989, The British journal of dermatology.
[85] C. Miller,et al. Ability of 15-hydroxyeicosatrienoic acid (15-OH-20:3) to modulate macrophage arachidonic acid metabolism. , 1988, Biochemical and biophysical research communications.
[86] R. Chapkin,et al. Inability of murine peritoneal macrophages to convert linoleic acid into arachidonic acid. Evidence of chain elongation. , 1988, Journal of immunology.
[87] R. Bryant,et al. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2. , 1985, The Journal of biological chemistry.
[88] O. Mercuri,et al. Metabolism of gammalinolenic acid by human blood platelet microsomes. , 1985, Biochemistry international.
[89] V. Ziboh,et al. Inability of skin enzyme preparations to biosynthesize arachidonic acid from linoleic acid. , 1984, Biochemical and biophysical research communications.
[90] D. Horrobin,et al. TREATMENT OF ATOPIC ECZEMA WITH EVENING PRIMROSE OIL , 1981, The Lancet.
[91] R. Bryant,et al. Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. , 1980, The Journal of biological chemistry.
[92] M. Hamberg,et al. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. , 1976, The Journal of biological chemistry.
[93] J. Oates,et al. Increased arachidonate in lipids after administration to man: Effects on prostaglandin biosynthesis , 1975, Clinical pharmacology and therapeutics.
[94] H. Sprecher,et al. Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids. , 1975, Biochimica et biophysica acta.
[95] M. Hamberg,et al. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[96] R. Fendall. CONTRIBUTIONS TO THE LANCET , 1975, The Lancet.
[97] F. Vane,et al. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. , 1974, Prostaglandins.
[98] J. Paulsrud,et al. Dihomo-γ-linolenate suppresses platelet aggregation when administered in vitro or in vivo , 1974 .
[99] M. Hamberg,et al. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[100] W. Lands,et al. Oxygenation of polyunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular gland. , 1972, Biochemistry.
[101] G. Burr,et al. On the Fatty Acids Essential in Nutrition.∗ , 1933 .
[102] G. Burr,et al. ON THE FATTY ACIDS ESSENTIAL IN NUTRITION. III , 1932 .
[103] G. Burr,et al. Nutrition classics from The Journal of Biological Chemistry 82:345-67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. , 1929, Nutrition reviews.
[104] D. Andersson,et al. Efficacy and safety , 2018 .
[105] J. Heuvel. Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids. , 2012 .
[106] J. V. Vanden Heuvel. Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids. , 2012, Progress in molecular biology and translational science.
[107] H. Kachi,et al. Dietary supplementation of gamma-linolenic acid improves skin parameters in subjects with dry skin and mild atopic dermatitis. , 2011, Journal of oleo science.
[108] T. Rice,et al. Enteral Omega-3 Fatty Acid ,-Linolenic Acid , and Antioxidant Supplementation in Acute Lung Injury , 2011 .
[109] M. Surette,et al. The impact of a medical food containing gammalinolenic and eicosapentaenoic acids on asthma management and the quality of life of adult asthma patients. , 2008, Current medical research and opinion.
[110] V. Ziboh. The significance of polyunsaturated fatty acids in cutaneous biology , 2007, Lipids.
[111] J. Daly. Effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shockPontes-Arruda A, Aragão AMA, Albuquerque JD (Fernandes Távora Hosp, Fortaleza, Ceará, Brazil; Latin American Sepsis Inst, São Paulo, Brazil , 2007 .
[112] L. Iversen,et al. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway , 2004, Archives of Dermatological Research.
[113] P. Dagnelie,et al. - Linolenic acid supplementation for prophylaxis of atopic dermatitis — a randomized controlled trial in infants at high familial risk 1 – 3 , 2003 .
[114] C. Miller,et al. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. , 2000, The American journal of clinical nutrition.
[115] D. Horrobin. Essential fatty acid metabolism and its modification in atopic eczema. , 2000, The American journal of clinical nutrition.
[116] A. Hill,et al. Evening primrose oil and borage oil in rheumatologic conditions. , 2000, The American journal of clinical nutrition.
[117] S. Clarke,et al. Regulation of gene expression by dietary fat. , 1999, Annual review of nutrition.
[118] D. Kyle,et al. The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans , 1997, Lipids.
[119] C. Irazú,et al. Delta 5 desaturase activity in rat kidney microsomes. , 1993, Molecular and cellular biochemistry.
[120] V. Ziboh,et al. Dose-response effects of dietary gamma-linolenic acid-enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4. , 1992, The American journal of clinical nutrition.
[121] R. Zurier. Role of prostaglandins E in inflammation and immune responses. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.
[122] Zurier Rb. Role of prostaglandins E in inflammation and immune responses. , 1991 .
[123] H. Schumacher,et al. Suppression of acute and chronic inflammation by dietary gamma linolenic acid. , 1989, The Journal of rheumatology.
[124] P. Ward,et al. Suppression of chronic inflammation by evening primrose oil. , 1981, Progress in lipid research.
[125] M. Lagarde,et al. Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid. , 1981, Progress in lipid research.
[126] H. Sprecher,et al. Biochemistry of essential fatty acids. , 1981, Progress in lipid research.
[127] G. Fülgraff. Prostaglandins and inflammation. , 1974, Advances in clinical pharmacology.
[128] J. Paulsrud,et al. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo. , 1974, Prostaglandins.